ClinicalTrials.Veeva
Menu

Find clinical trials for Triple Negative Breast Cancer in Kansas City, KS

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Breast Cancer
Cancer
Carcinoma
Squamous Cell Carcinoma of Head and Neck
Endometrial Cancer
Non-Small-Cell Lung Carcinoma
Ovarian Epithelial Carcinoma

Triple Negative Breast Cancer trials near Kansas City, KS, USA:

Neoadjuvant Phase II Study of Pembrolizumab And Carboplatin Plus Docetaxel in Triple Negative Breast Cancer (NeoPACT)

The standard treatment for women with stage I, II, and III triple-negative breast cancer (TNBC) includes chemothe ...

Active, not recruiting
Triple-negative Breast Cancer
Drug: Pegfilgrastim
Drug: Carboplatin

Phase 2

University of Kansas
University of Kansas

Kansas City, Kansas, United States and 8 other locations

Study combination use of cisplatin plus romidepsin and nivolumab in metastatic triple negative breast cancer (TNB ...

Active, not recruiting
Breast Cancer
Triple-Negative Breast Cancer
Drug: Cisplatin
Drug: Romidepsin

Phase 1, Phase 2

Priyanka Sharma

Kansas City, Kansas, United States and 6 other locations

Locations recently updated

and capecitabine) for the treatment of first-line metastatic triple-negative breast cancer (TNBC) or estrogen rec...

Begins enrollment in 2 months
Breast Neoplasms
Drug: Paclitaxel
Drug: Iza-bren

Phase 2, Phase 3

Bristol-Myers Squibb (BMS)
Bristol-Myers Squibb (BMS)

Kansas City, Missouri, United States and 217 other locations

previously untreated, locally advanced, inoperable or metastatic triple-negative breast cancer whose tumors...

Enrolling
Triple Negative Breast Cancer
PD-L1 Negative
Drug: Sacituzumab Govitecan-hziy
Drug: Paclitaxel

Phase 3

Gilead Sciences
Gilead Sciences

Kansas City, Kansas, United States and 516 other locations

with previously untreated, locally advanced inoperable or metastatic triple-negative breast cancer, whose tumors...

Active, not recruiting
Triple Negative Breast Cancer
PD-L1 Positive
Drug: Pembrolizumab
Drug: Carboplatin

Phase 3

Gilead Sciences
Gilead Sciences

Kansas City, Kansas, United States and 505 other locations

with stage I to III TNBC with residual invasive disease in the breast and/or axillary lymph nodes at surgical resection following neoadjuvan...

Active, not recruiting
Breast Cancer
Drug: Pembrolizumab
Drug: Dato-DXd

Phase 3

AstraZeneca
AstraZeneca

Westwood, Kansas, United States and 275 other locations

III Study of Capivasertib + Paclitaxel versus Placebo + Paclitaxel as First line Treatment for Patients with Locally Advanced or Metastatic Triple...

Active, not recruiting
Triple Negative Breast Neoplasms
Drug: Capivasertib
Drug: Placebo

Phase 3

AstraZeneca
AstraZeneca

Westwood, Kansas, United States and 257 other locations

Recently updated

This study will test the safety, including side effects, and determine the characteristics of a drug called Rina-S in participants with solid tumors...

Enrolling
Uterine Cancer
Hormone Receptor-positive/Her2 Negative Breast Cancer
Drug: Carboplatin
Drug: Pembrolizumab

Phase 1, Phase 2

Genmab
Genmab

Westwood, Kansas, United States and 36 other locations

-small-cell lung cancer (NSCLC), triple negative breast cancer (TNBC), ovarian cancer (OC), end...

Active, not recruiting
Castration-resistant Prostate Cancer
Lower Esophageal Cancer
Drug: cabozantinib
Drug: atezolizumab

Phase 1, Phase 2

Exelixis
Exelixis

Kansas City, Missouri, United States and 123 other locations

This clinical trial is studying solid tumor cancers. A solid tumor is one that starts in part of your body like your lungs ...

Enrolling
HER2 Positive Breast Neoplasms
HER2 Low Breast Neoplasms
Drug: disitamab vedotin
Drug: tucatinib

Phase 2

Seagen, a wholly owned subsidiary of Pfizer

Kansas City, Missouri, United States and 121 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems